Jill Autry
Optometrist · Bellaire, TXNPI 1922001270
Payments from drug & device makers
Across 477 payments — averaging $359.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$147K
- Eyevance Pharmaceuticals LLC$12K
- Sun Pharmaceutical Industries Inc.$5K
- Sight Sciences, Inc.$1K
- Alcon$1K
- Johnson & Johnson Surgical Vision, Inc.$1K
- plus $4K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 267 | $147,353 |
| Eyevance Pharmaceuticals LLC | 21 | $11,714 |
| Sun Pharmaceutical Industries Inc. | 39 | $4,785 |
| Sight Sciences, Inc. | 10 | $1,306 |
| Alcon | 27 | $1,228 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $1,022 |
| Ivantis, Inc | 1 | $675 |
| Novartis | 25 | $639 |
| Tarsus Pharmaceuticals, Inc. | 10 | $378 |
| Oyster Point Pharma, Inc. | 13 | $370 |
| Aerie Pharmaceuticals, Inc. | 6 | $312 |
| Optos, Inc. | 4 | $280 |
| Dompe US, Inc. | 4 | $208 |
| Kala Pharmaceuticals, Inc. | 8 | $186 |
| Ocular Therapeutix, Inc. | 6 | $150 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $149 |
| Biotissue Holdings Inc. | 6 | $127 |
| Bausch & Lomb Americas Inc. | 5 | $84 |
| Amgen(2 entities) | 3 | $71 |
| Alcon Research LLC | 1 | $53 |
| Regeneron Healthcare Solutions, Inc. | 3 | $48 |
| Harrow Eye, LLC | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 2 | $45 |
| Biogen | 1 | $29 |
| Glaukos Corporation | 1 | $27 |
| Shire North American Group Inc | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| NEW World Medical,inc. | 1 | $7 |
How this compares
$171,324 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Bellaire
- Tiffany HuynhHouston$3.2M
- Bridgitte LeeHouston$3M
- Bryan FrazierTyler$1.4M
- Derek CunninghamAustin$940K
- Wendy ChungKaty$900K
- Phillip BrunsonHouston$766K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$568K
- Mina VanrachackSan Antonio$553K
- Luis RojasMcKinney$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.